Nirsevimab
id:
nirsevimab-162-6734891
title:
Nirsevimab
text:
Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). It is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor that is designed to bind to the fusion protein on the surface of the RSV virus. The most common side effects are rash, fever and injection site reactions. It was developed by AstraZeneca and Sanofi. Nirsevimab was approved for medical use in both the European Union and the
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody used as vaccine against RSV
original url:
https://en.wikipedia.org/wiki/Nirsevimab
date created:
2021-12-27T07:19:26Z
date modified:
2024-08-27T15:43:41Z
main entity:
{"identifier":"Q111535760","url":"https://www.wikidata.org/entity/Q111535760"}
image:
fields total:
13
integrity:
15